Galderma Research & Development

51 patents currently held · Updated Nov 14, 2026

7 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 9 name spellings.

Ending by 2030

Jul 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Nov 14, 2026
The maintenance fee for Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies (US 10,287,278) comes due Nov 14, 2026. Unpaid by May 14, 2027, it lapses early.
3 fees due Dec 9 to 23, 2026 · next Dec 9
2 fees due Jan 9 to 21, 2027 · next Jan 9
4 fees due Feb 11 to 22, 2027 · next Feb 11
2 fees due Mar 1 to 15, 2027 · next Mar 1
2 fees due Apr 22 to 29, 2027 · next Apr 22
1 fee due Aug 4, 2027
The maintenance fee for Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t)) (US 10,550,110) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
1 fee due Sep 1, 2027
The maintenance fee for Dermatological foams obtained from a gel or suspension containing adapalene (US 9,271,930) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

5 terms have ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,060,948	Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide In force Ends no later than Jul 11, 2027 · From the USPTO record	In force	Ends no later than Jul 11, 2027	From the USPTO record
US 8,080,537	Combinations of adapalene and benzoyl peroxide for treating acne lesions In force Term ends Jul 18, 2027 · From the USPTO record	In force	Term ends Jul 18, 2027	From the USPTO record
US 8,071,644	Combinations of Adapalene and Benzoyl Peroxide for Treating Acne Lesions In force Ends no later than Sep 4, 2027 · Medium confidence	In force	Ends no later than Sep 4, 2027	Medium confidence
US 7,872,026	Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof In force Term ends Feb 16, 2028 · From the USPTO record	In force	Term ends Feb 16, 2028	From the USPTO record
US 7,998,467	Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers In force Term ends May 31, 2028 · From the USPTO record	In force	Term ends May 31, 2028	From the USPTO record
US 8,758,805	Skin moisturizing compositions In force Term ends Aug 23, 2028 · From the USPTO record	In force	Term ends Aug 23, 2028	From the USPTO record
US 8,044,082	N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof In force Term ends Sep 5, 2028 · From the USPTO record	In force	Term ends Sep 5, 2028	From the USPTO record
US 8,957,112	Cream gels comprising at least one retinoid and benzoyl peroxide In force Ends no later than Oct 7, 2028 · Medium confidence	In force	Ends no later than Oct 7, 2028	Medium confidence
US 8,937,098	Dermatological Compositions Comprising at Least One Naphthoic Acid Compound and at Least One Film-Forming Agent and Treatment of Keratinization Disorders Therewith In force Term ends Oct 22, 2028 · High confidence	In force	Term ends Oct 22, 2028	High confidence
US 8,952,066	Pharmaceutical/Cosmetic, E.G., Anti-Acne Compositions Comprising at Least One Naphthoic Acid Compound, Benzoyl Peroxide and at Least One Film-Forming Agent In force Term ends Oct 22, 2028 · High confidence	In force	Term ends Oct 22, 2028	High confidence

10 of 51 patents shown.

Pro members see all 51.

Pro members: see all 51 patents

Also on record, not counted in the 51: 7 patents in force now held by others · 171 lapsed for an unpaid fee · 42 ended at full term · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 abandoned · 186 no status recorded

List them